Concepedia

Oluwatomisin T. Atolagbe

OT

Statistics

Publications

5

Citations

441

H-Index

5

Active since

2015

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Parker Institute for Cancer Immunotherapy

National Institute of Environmental Health Sciences

Oluwatomisin T. Atolagbe is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, tumor biology, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2015–2024

5

Publications

5

A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention

Spencer C. Wei, Wouter C. Meijers, Margaret L. Axelrod et al. · Cancer Discovery · 2020 · 247 citations · Full text

LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy

Naveen Sharma, Oluwatomisin T. Atolagbe, Zhongqi Ge et al. · The Journal of Experimental Medicine · 2021 · 121 citations · Full text

ICOS costimulation in combination with CTLA-4 blockade remodels tumor-associated macrophages toward an antitumor phenotype

Naveen Sharma, Xiaozhou Fan, Oluwatomisin T. Atolagbe et al. · The Journal of Experimental Medicine · 2024 · 34 citations · Full text

, , +24

OKN-007 decreases free radical levels in a preclinical F98 rat glioma model

Patrícia Coutinho de Souza, Nataliya Smith, Oluwatomisin T. Atolagbe et al. · Free Radical Biology and Medicine · 2015 · 23 citations · Full text

, , +9

Deep Transcriptomic Profiling of M1 Macrophages Lacking Trpc3

Sivarajan Kumarasamy, S. K. Solanki, Oluwatomisin T. Atolagbe et al. · Scientific Reports · 2017 · 16 citations · Full text

Rows per page

1–5 of 5